Endo Health Solutions (NSDQ:ENDP) said today that it plans to write down the value of its American Medical Systems acquisition.
American Medical Systems Holdings Inc.
Bard mesh cases slated for discovery
American Medical Systems wins 510(k) clearance for transvaginal sling
American Medical Systems lands CE Mark for transvaginal sling
Pelvic mesh makers look to settle lawsuits
Five medical device companies that make pelvic mesh implants are hoping to negotiate settlements for the more than 30,000 pending lawsuits they’re facing in the U.S., anonymous sources told Bloomberg.
Endo Health’s American Medical Systems to settle mesh lawsuits for $55M
Endo Health Solutions (NSDQ:ENDP) subsidiary American Medical Systems said it’s agreed to pay $54 million to settle personal injury lawsuits filed over its pelvic mesh products.
Australia issues warning on American Medical Systems’ urinary control systems
Australian healthcare regulators issued a safety advisory late last month on certain lots of American Medical Systems’ AMS 800 urinary control systems, warning that the devices were released on the market on the market without meeting the company’s product release criteria.
AMS recalls its AdVance Male Sling System
American Medical Systems Europe BV recalled certain lots of its AdVance Male Sling Systems, warning that the absorbable sutures in the AdVance sling might not last as long as expected on the shelf.
Medical device companies: Who spends the most on R&D?
Across the medical device industry, R&D spending in 2011 increased despite a lethargic economy, job cuts and reorganization mandates by a number of big-name companies.
Johnson & Johnson sold vaginal mesh product for 3 years without FDA clearance, report says
Health care giant Johnson & Johnson (NYSE:JNJ) found itself again in the hot seat as new reports claim the company sold a transvaginal mesh product in the U.S. for 3 years before obtaining appropriate FDA clearance.
Johnson & Johnson vaginal mesh lawsuits another blow to the FDA’s device review process
The FDA’s medical device review process is again under scrutiny as lawsuits pile up against health care leviathan Johnson & Johnson (NYSE:JNJ) for transvaginal mesh devices that may do more harm than good.
Lawsuits claiming negligence against mesh-makers have also implicated the FDA’s review system for continuing to clear new mesh products under the 510(k) system, despite the predicate device being pulled from U.S. shelves.